Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

Kennedy SH, Evans KR, Kr├╝ger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ.

Am J Psychiatry. 2001 Jun;158(6):899-905.

PMID:
11384897
2.

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR Jr.

Arch Gen Psychiatry. 2001 Jul;58(7):631-40.

PMID:
11448368
3.

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr.

Am J Psychiatry. 2003 Mar;160(3):522-32.

PMID:
12611834
4.

Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.

Smith GS, Reynolds CF 3rd, Pollock B, Derbyshire S, Nofzinger E, Dew MA, Houck PR, Milko D, Meltzer CC, Kupfer DJ.

Am J Psychiatry. 1999 May;156(5):683-9.

PMID:
10327899
5.

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.

Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K, Baxter LR Jr.

Psychiatry Res. 1999 Oct 11;91(3):127-39.

PMID:
10641577
6.

Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.

Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS.

Am J Psychiatry. 2007 May;164(5):778-88.

PMID:
17475737
7.

Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.

Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H.

Arch Gen Psychiatry. 2004 Jan;61(1):34-41.

PMID:
14706942
8.

Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.

Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2002 Feb 1;51(3):237-52.

PMID:
11839367
9.

Decreased regional brain metabolism after ect.

Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, Mann JJ.

Am J Psychiatry. 2001 Feb;158(2):305-8.

PMID:
11156816
10.

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.

Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, Houle S.

Am J Psychiatry. 2001 Nov;158(11):1843-9.

PMID:
11691690
11.

Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.

New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V, Sprung L, Shaw RB Jr, Koenigsberg H, Platholi J, Silverman J, Siever LJ.

Arch Gen Psychiatry. 2002 Jul;59(7):621-9.

PMID:
12090815
12.

Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.

Ho AP, Gillin JC, Buchsbaum MS, Wu JC, Abel L, Bunney WE Jr.

Arch Gen Psychiatry. 1996 Jul;53(7):645-52.

PMID:
8660131
13.

Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex.

Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE Jr, Fallon JH, Keator D.

Am J Psychiatry. 1999 Aug;156(8):1149-58. Erratum in: Am J Psychiatry 1999 Oct;156(10):1666.

PMID:
10450253
14.

Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Milak MS, Parsey RV, Lee L, Oquendo MA, Olvet DM, Eipper F, Malone K, Mann JJ.

Psychiatry Res. 2009 Jul 15;173(1):63-70. doi: 10.1016/j.pscychresns.2008.09.004. Epub 2009 May 14.

15.

Alterations in regional cerebral glucose metabolism across waking and non-rapid eye movement sleep in depression.

Nofzinger EA, Buysse DJ, Germain A, Price JC, Meltzer CC, Miewald JM, Kupfer DJ.

Arch Gen Psychiatry. 2005 Apr;62(4):387-96.

PMID:
15809406
16.

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.

Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS.

Arch Gen Psychiatry. 1997 Apr;54(4):364-74.

PMID:
9107153
17.
18.

The functional neuroanatomy of the placebo effect.

Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA.

Am J Psychiatry. 2002 May;159(5):728-37.

PMID:
11986125
19.

Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using.

Nofzinger EA, Berman S, Fasiczka A, Miewald JM, Meltzer CC, Price JC, Sembrat RC, Wood A, Thase ME.

Psychiatry Res. 2001 Apr 10;106(2):95-111.

PMID:
11306249
20.

Feeling unreal: a PET study of depersonalization disorder.

Simeon D, Guralnik O, Hazlett EA, Spiegel-Cohen J, Hollander E, Buchsbaum MS.

Am J Psychiatry. 2000 Nov;157(11):1782-8.

PMID:
11058475

Supplemental Content

Support Center